4 March, 2015 by The TZ Newswire Staff Comments Off on U.S. Fed struggled with 2009 bailouts, bond-buying: transcripts
U.S. Fed struggled with 2009 bailouts, bond-buying: transcripts
WASHINGTON/NEW YORK (Reuters) – The Federal Reserve struggled with the message being sent by its role in bank bailouts and worried about the impact of a bond-buying program aimed at easing the 2007-2009 financial crisis, according to transcripts released by the U.S. central bank on Wednesday. The transcripts from Fed meetings in 2009 reveal intense discussions on how to prop up the U.S. banking system and nurse an economy reeling from the biggest financial shocks since the Great Depression.
4 March, 2015 by The TZ Newswire Staff Comments Off on UBS poaches executives from Evercore for its U.S. unit: WSJ
UBS poaches executives from Evercore for its U.S. unit: WSJ
Brett Pickett, Lowell Strug, and Peter Kuhn are set to join the UBS unit, according to the internal memo from Ros Stephenson, head of the bank’s Americas advisory unit, the WSJ said.
4 March, 2015 by The TZ Newswire Staff Comments Off on Movers & Shakers: Costco, Kroger, Joy Global earnings in focus
Movers & Shakers: Costco, Kroger, Joy Global earnings in focus
Among the companies whose shares are expected to see active trade in Thursday’s session are Costco, Kroger, and Joy Global.
read more
4 March, 2015 by The TZ Newswire Staff Comments Off on The Circus Is In Town
The Circus Is In Town
Posted with permission by Gary Christenson – The Deviant Investor
A three ring circus is performing – to entertain and impoverish the western world.
Ring # 1: The Euro tragedy is “extending and pretending” into a Greek drama.
4 March, 2015 by The TZ Newswire Staff Comments Off on Brazil’s rate hikes tip country closer to recession
Brazil’s rate hikes tip country closer to recession
Brazil hiked interest rates to a six-year high on Wednesday, but economists say the move only serves to push the economy to the brink of recession.
4 March, 2015 by The TZ Newswire Staff Comments Off on AbbVie to buy Pharmacyclics in $21 billion deal
AbbVie to buy Pharmacyclics in $21 billion deal
Drugmaker AbbVie said it will buy Pharmacyclics for about $21 billion to boost its oncology drugs pipeline.